| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |